NewswireToday - /newswire/ -
Noida, Uttar Pradesh, India, 2010/07/12 - The US cellular therapeutics market is projected to grow at a CAGR of around 56% between 2010 and 2012, says a new research report from RNCOS.
The US is the major stem cell market in the world as the country is witnessing large number of transplantations and has an emerging cord blood banking market. It has been showing tremendous growth from last year after the government lifted the ban on stem cell funding. Also, the demand for the discovery of novel drugs is increasing, which is boosting the demand for stem cell applications.
According to our research report “US Stem Cell Market Analysis”, cellular therapeutics will be driving the growth of the stem cell industry and will grow at a CAGR of around 56% between 2010 and 2012. Since cells, unlike organs are renewable sources and can be repaired and regenerated, cellular therapies are playing a key role in the area of medicine. Also, cellular therapies are more effective and accurate in treating the diseases. Besides this, the main reason for the growth of the market is the increasing interest of the pharma majors in the development of personalized medicines.
Our team of experts has done an extensive research on the US stem cell market and has categorized it into Therapeutic Banking and Cellular Therapeutics on the basis of technology. We have further segmented the stem cell products into adult stem cells and embryonic stem cells. It also covers various emerging areas for the therapeutic applications such as Spinal Cord Injury, Myocardial Infarction, etc. Various factors which will drive the demand of the stem cell industry, such as Cord Blood Banking and Regenerative Medicines, have also been discussed in detail.
To better gauge the future success of the stem cell market in the US, “US Stem Cell Market Analysis” provides detailed forecast on the stem cell industry, cellular therapeutics market, therapeutics banking market and stem cell product sales. Most importantly, our research identifies the important role played by the healthcare regulatory in fuelling the growth of the industry because of which we have discussed regulatory framework in detail. The report also covers analysis on the competitive environment of the stem cell industry. The section provides information on company overview and business strategies of prominent industry players currently operating in the sector.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.